迈得医疗
(688310)
| 流通市值：19.51亿 | | | 总市值：19.51亿 |
| 流通股本：1.66亿 | | | 总股本：1.66亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 219,574,032.71 | 165,394,581.71 | 74,220,852.42 | 480,220,256 |
| 营业收入 | 219,574,032.71 | 165,394,581.71 | 74,220,852.42 | 480,220,256 |
| 二、营业总成本 | 236,252,326.53 | 166,500,744.77 | 71,608,393.2 | 384,333,032.62 |
| 营业成本 | 112,296,942.2 | 83,393,266.77 | 34,507,374.64 | 229,198,523.48 |
| 税金及附加 | 4,749,812.52 | 3,391,532.34 | 1,466,181.49 | 6,880,612.24 |
| 销售费用 | 21,646,541.66 | 14,277,868.18 | 5,296,950.73 | 32,212,873.29 |
| 管理费用 | 70,982,904.91 | 47,372,545.46 | 21,440,815.64 | 90,429,822.31 |
| 研发费用 | 28,854,806.83 | 20,296,139.69 | 9,880,803.8 | 33,176,643.68 |
| 财务费用 | -2,278,681.59 | -2,230,607.67 | -983,733.1 | -7,565,442.38 |
| 其中:利息费用 | 51,104.61 | 45,060.05 | 24,179.1 | 76,290.31 |
| 其中:利息收入 | 2,510,344.61 | 2,376,925.95 | 1,099,878.8 | 7,193,230.28 |
| 加:公允价值变动收益 | 2,231,445.22 | 1,286,962.15 | 591,418.33 | 2,659,119.87 |
| 加:投资收益 | -49,138.39 | -20,711.79 | 8,557.05 | 65,440.87 |
| 资产处置收益 | 481,041.13 | 144,230.1 | 130,401.41 | 101,695.82 |
| 资产减值损失(新) | -753,453.27 | -653,573.33 | -377,939 | -2,255,424.47 |
| 信用减值损失(新) | 213,832.51 | 1,312,264.02 | 1,575,038.97 | -3,221,085.35 |
| 其他收益 | 19,850,037.76 | 9,511,177.08 | 6,048,219.18 | 34,734,488.93 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 5,295,471.14 | 10,474,185.17 | 10,588,155.16 | 127,971,459.05 |
| 加:营业外收入 | 316,124.55 | 15,114.35 | 1,400 | 421,633.04 |
| 减:营业外支出 | 1,007,644.05 | 403,324.7 | 101,405.31 | 962,159.13 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 4,603,951.64 | 10,085,974.82 | 10,488,149.85 | 127,430,932.96 |
| 减:所得税费用 | 2,571,423.73 | 3,027,592.82 | 873,990.62 | 17,823,654.82 |
| 六、净利润 | 2,032,527.91 | 7,058,382 | 9,614,159.23 | 109,607,278.14 |
| 持续经营净利润 | 2,032,527.91 | 7,058,382 | 9,614,159.23 | 109,607,278.14 |
| 归属于母公司股东的净利润 | 7,629,882.29 | 9,879,902.6 | 10,513,161.2 | 99,828,173.71 |
| 少数股东损益 | -5,597,354.38 | -2,821,520.6 | -899,001.97 | 9,779,104.43 |
| (一)基本每股收益 | 0.05 | 0.06 | 0.09 | 0.85 |
| (二)稀释每股收益 | 0.05 | 0.06 | 0.09 | 0.84 |
| 八、其他综合收益 | 19,336.48 | 183,491.61 | 174,622.57 | -415,959.28 |
| 归属于母公司股东的其他综合收益 | 19,336.48 | 183,491.61 | 174,622.57 | -415,959.28 |
| 九、综合收益总额 | 2,051,864.39 | 7,241,873.61 | 9,788,781.8 | 109,191,318.86 |
| 归属于母公司股东的综合收益总额 | 7,649,218.77 | 10,063,394.21 | 10,687,783.77 | 99,412,214.43 |
| 归属于少数股东的综合收益总额 | -5,597,354.38 | -2,821,520.6 | -899,001.97 | 9,779,104.43 |
| 公告日期 | 2024-10-30 | 2024-08-31 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |